ctrl K

AI Score

Unlock

Autolus Therapeutics (AUTL)

AI Score

Unlock

1.33

-0.18 (-11.92%)

At close: Apr 04, 2025, 3:59 PM

1.39

4.20%

After-hours: Apr 04, 2025, 05:58 PM EDT

Autolus Therapeutics Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2020	Sep 30, 2020
License Revenue	0	10.1M	0	242K
License Revenue Growth	-100.00%	n/a	-100.00%	n/a

Revenue by Geography

Quarter	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States Revenue	1.35M	6.19M	1.51M
United States Revenue Growth	-78.17%	+311.02%	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016
Selling, General, and Administrative Revenue	27.33M	21.9M	16.37M	13.95M	10.61M	11.12M	9.28M	7.41M	8.23M	8.27M	7.99M	7.59M	8.3M	7.24M	8.74M	9.01M	9.84M	8.51M	7.61M	9.92M	8.61M	11.37M	9.56M	7.59M	7.27M	6.8M	4.33M	2.89M	2.89M	1.66M	1.66M
Selling, General, and Administrative Revenue Growth	+24.78%	+33.79%	+17.33%	+31.50%	-4.59%	+19.80%	+25.26%	-9.95%	-0.46%	+3.53%	+5.22%	-8.53%	+14.67%	-17.18%	-2.98%	-8.50%	+15.68%	+11.75%	-23.25%	+15.29%	-24.32%	+18.98%	+25.85%	+4.40%	+6.91%	+57.11%	+50.03%	n/a	+73.49%	n/a	n/a
Research and Development Revenue	40.32M	36.61M	30.67M	25.16M	37.24M	36.74M	31.34M	32.19M	37.63M	38.21M	33.96M	39.63M	32.29M	32.13M	30.73M	38.73M	33.55M	31.33M	31.29M	29.37M	27.31M	26.17M	22.57M	17.71M	10.15M	8.86M	11.69M	4.6M	4.6M	3.51M	3.51M
Research and Development Revenue Growth	+10.14%	+19.37%	+21.91%	-32.44%	+1.35%	+17.22%	-2.62%	-14.47%	-1.52%	+12.51%	-14.31%	+22.74%	+0.50%	+4.56%	-20.65%	+15.45%	+7.08%	+0.13%	+6.53%	+7.54%	+4.34%	+15.99%	+27.39%	+74.53%	+14.51%	-24.20%	+154.17%	n/a	+31.20%	n/a	n/a